Canada has a vibrant life sciences and pharmaceutical industry, with a broad array of firms conducting research and developing innovative medicines, generic medicines, biosimilar products, consumer health-care products and medical devices.
These companies, which range from university-supported start-ups to multinational drug companies, are key to the commercialization of life sciences in Canada.
Originally published 26 June, 2020
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
For permission to reprint articles, please contact the Blakes Marketing Department.
© 2020 Blake, Cassels & Graydon LLP.
